Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MET

Metlife Inc Declares Q3 Preferred Stock Dividends

Metlife, Inc. (NYSE: MET) has declared its preferred stock dividends for the third quarter of 2025. Shareholders of the company’s floating rate non-cumulative preferred stock, Series A, will receive a quarterly dividend of $0.35263005 per share. Additionally, the semi-annual dividend for the 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, is set at $29.375 per share. For the 5.625% non-cumulative preferred stock, Series E, the quarterly dividend stands at $351.5625 per share, while the 4.75% non-cumulative preferred stock, Series F, will pay out a quarterly dividend of $296.875 per share. Lastly, the semi-annual dividend for the 3.850% fixed rate reset non-cumulative preferred stock, Series G, is $19.250 per share.

These dividends, totaling a significant amount, will be payable on September 15, 2025, to shareholders of record as of August 29, 2025. This record date has been adjusted due to its occurrence on a Sunday, shifting to Friday, August 29, 2025.

Metlife, Inc. continues to be a leading financial services company, offering insurance, annuities, employee benefits, and asset management to customers globally. Founded in 1868, the company operates in more than 40 markets worldwide and holds prominent positions in the United States, Asia, Latin America, Europe, and the Middle East. Following these announcements, the company's shares moved -0.76%, and are now trading at a price of $77.33. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS